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ABSTRACT
Background: Immunization is said to be the most effective public health intervention to
prevent morbidity, complications, and mortality due to infectious disease among children.
Due to the importance of vaccination in terms of infectious disease prevention, in terms
of high cost-effectiveness ratio, international organizations, governments, and donors
have intensified efforts to increase immunization coverage globally. Despite the efforts,
thousands of children remain unimmunized or not fully vaccinated worldwide.
Objective: To identify factors associated with incomplete immunization among children
in Côte d’Ivoire.
Method: The 1998-1999 and 2011-2012 Côte d’Ivoire Demography and Health Survey
(DHS) data were used in this study. The included 3878 children aged 12 to 59 months
with 1326 children from 1998-1999 DHS, and 2552 children from 2011-2012 DHS.
Descriptive analysis was performed. Spearman’s correlation coefficient was computed to
examine the relationship between variables. Univariate analysis was performed to
examine the association between the dependent variable (incomplete immunization) and
each independent variable using logistic regression. Variables with a p-value less than .05
in the univariate analysis were included in the multivariate analysis. Multivariate analysis
was performed to determine predictors of immunization status using logistic regression
(stepwise method).
Results: About 42.7% and 50.1% of Côte d’Ivoire were not fully immunized in 19981999 and 2011-2012, respectively. Child birth place, mothers’ access to media, mothers’
literacy, place of residence, and religion were the best predictors of incomplete
immunization.
Conclusion: Health authorities in Côte d’Ivoire should take into account these
immunization status predictors in order to address the issue of incomplete immunization.
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CHAPTER I
INTRODUCTION
Background
Immunization or vaccination is defined as “the artificial induction of active immunity by
introducing into a vulnerable host the specific antigen (living modified agent, killed
organism, or inactivated toxin) of a pathogenic organism” (Porta, 2008). Immunization
has a huge impact on populations’ health worldwide. Due to immunization, small pox
which accounted for 300 to 500 million deaths (Smallpox-related virus, 2010) was
eradicated in 1980 as reported by Henderson (1999), and Etana and Deressa (2012). To
build on small pox eradication, the World Health Organization (WHO) established the
Expended Program on Immunization (EPI) in 1974 as reported by WHO (2013a), and
Bugvi et al. (2014). Vaccination plays a major role in infectious disease prevention. It is
said to be the most effective public health intervention to prevent morbidity,
complications, and mortality due to infectious disease among children as reported by the
National Institute of Public Health of Quebec (2007), Antai (2009), and Odusanya,
Alufohai, Meurice, and Ahonkhai (2008). According to the WHO, each year,
immunization prevents an estimated 2.5 thousand child deaths (2009a, 2013a). Due to the
large number of deaths averted by immunization and the financial benefit it provides,
immunization is listed among the most cost-effective public health intervention as
mentioned by Edwards (2010), the WHO, UNICEF, and the World Bank (2009), and the
Global Alliance for Vaccines and Immunization (2001). Small pox eradiation costs, for
example, estimated in US$ 100 million resulted in an estimated savings of US$ 1.3
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billion as reported by the WHO, UNICEF, and the World Bank (2009), and Bloom,
Canning, and Weston (2005). In addition, studies showed that every dollar spent in
Measles-Mumps-Rubella (MMR) vaccine, and Diphtheria- Tetanus -Pertussis (DTP)
vaccine produces US$ 21 and US$ 24 savings respectively in direct medical costs
(Armstrong, 2007). Moreover, a study conducted in United States (US) found that for
every dollar spent, the routine immunization program saves in direct cost and in
additional cost to society more than $5 and about $11 respectively (Zhou et al., 2005).
Knowing the importance of vaccination in terms of infectious disease prevention,
and its good cost-effective ratio, international organizations, governments, and donors
have intensified their efforts to increase immunization coverage globally (Machingaidze,
Wiysonge, and Hussey, 2013) in general, and particularly in countries with less than 80%
coverage at district level, and less than 90% at national level. Despite these joint efforts,
thousands of children remain unimmunized or not fully vaccinated worldwide. For
instance, according to the WHO, in 2012, the global number of children who did not
receive the first dose of DPT, and those who did not receive the third dose were estimated
to 12.6 and 22.6 million respectively (2013b).
Studies have been conducted in different countries to identify determinants of
childhood immunization (Stronegger, and Freidl, 2009; Han, 2014; Nath et al., 2007).
Research found that parental education (Bosch-Capblanch, Banerjee, and Burton, 2012;
Wiysonge, Uthman, Ndumbe, and Hussey, 2012), maternal knowledge (Owais, Hanif ,
Siddiqui, Agha, and Zaidi, 2011; Etana, and Deressa, 2012), antenatal care (Hu, Li, Chen,
Chen, and Qi, 2013; Sia, Kobiané, Sondo, and Fournier, 2007), child birth place (Maina,
Karanja, and Kombich, 2013; Komlan et al., 2005), place of residence (Payne, Townend,
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Jasseh, Jallow, and Kampmann, 2013; Fernancez., Awofeso, and Rammohan, 2011;
Acosta-Ramirez, Duran-Arenas, Eslava-Rincon, and Campuzano-Rincon, 2005),
household wealth (Edwards, 2010; Roy, 2010), mother’s age (Waldhoer, Haidinger,
Vutuc, Haschke, and Plank, 1997), and family size (Maina, et al., 2013; Acosta-Ramirez
et al., 2005) were associated with childhood vaccination. These studies examined sociodemographic factors associated with immunization in a given year but not over the time.
Therefore, it appears useful to identify factors associated with immunization status
among children in Côte d’Ivoire, and determine the trends of these factors, in order to
inform health policy makers in general, and particularly Expanded Program on
Immunization (EPI) managers, in order to achieve immunization coverage objectives.
Research question
Do factors that are associated with children incomplete immunization change over the
time in Côte d’Ivoire?
Hypotheses
Null hypothesis (H0): Factors that are associated with childhood routine immunization
status do not change over the time in Côte d’Ivoire.
Alternative hypothesis (H1): Factors associated with childhood routine immunization
vary over the time in Côte d’Ivoire.
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CHAPTER II
LITERATURE REVIEW
Country profile
Côte d’Ivoire is a West African country which covers an area of 124, 500 square
mile (322 462 km2). Its neighboring countries are Ghana on the East, Guinea on the West,
Mali and Burkina-Faso on the North; on the South the country is limited by the Atlantic
Ocean (Direction de Coordination du Programme Elargi de vaccination, 2011a). The
climate in the southern part of the country is an equatorial climate with dense forest, and
in the northern part it is a tropical climate with savanna and woodland. There are many
watercourses across the country, and four main rivers that are Comoe (720 miles),
Bandama (652.4 miles), Cavally (435 miles), and Sassandra (403.9 miles) (Direction de
Coordination du Programme Elargi de vaccination, 2011b).
The landscape is composed of plateaus which rise on the Northwest and fall on the
coastal plain on the South bordered by lagoons (Direction de Coordination du Programme
Elargi de vaccination, 2011a). There are 60 ethnic groups in the country, which are
classified in 4 groups (Akan, Gour, Mande, and Krou). The most common religions are
Animism, Christianity, and Islam (Direction de Coordination du Programme Elargi de
vaccination, 2011b). According to UNICEF, in 2012, the population was estimated to be
19,839,800 with 9,557,000 people under 18 years, and 3,088,200 children under 5 years
of age. In the same year, urban population was estimated at 52%, and the adult literacy
rate was estimated to 56.9% (2013).
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Côte d’Ivoire has experienced a sociopolitical crisis since 2002. This crisis
worsened by the end of 2010 after the presidential elections followed by an armed
conflict. The post-electoral crisis had a negative impact on the health system in general
and particularly on vaccination program. Loss of cars, motorbikes, and cold chain
equipment were common in most of health districts. In addition, the adverse impact of the
crisis on the economy resulted in a government decreased funding of health sector
(Direction de Coordination du Programme Elargi de vaccination, 2011a). Moreover,
financial institutions and private companies closed for security reasons. As a result, the
Gross Domestic Product (GDP) expectedly dropped by 7.3%. However, an economic
growth of 5.5% was forecasted in 2012 (5.9%) if the social and security situation
normalized in the second half of 2011 (Direction de Coordination du Programme Elargi
de vaccination, 2011b).
In Côte d’Ivoire, there are three tiers of health care system. The first level is
composed of First Contact Health Facilities with 1680 immunization centers. The second
level includes general hospitals, specialized hospitals, and regional hospitals. The third
level is composed of four university hospital, and seven specialized institutes. It is
important to mention that the first level reference is the second level which reference
level is the third level. There is an unbalanced distribution of health facilities. For
example, Abidjan 1 and Lagunes 2 regions, where 20% of EPI target population live,
includes about 40% of urban health facilities, and 65% of centers for maternal and child
health.
There are 20 health regions and 82 health districts in the country. Activities of health
regions and districts are coordinated by the Ministry of health. Health regions and
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districts receive financial and technical support from partners such as the WHO,
UNICEF, GAVI Alliance, International ROTARY, Red Cross International Comity,
Japan cooperation (Ministère de la Sante et de la Lutte contre le Sida, 2012).
Expanded Program on Immunization in Cote d’Ivoire
The EPI started in Côte d’Ivoire in 1978 under a pilot project in the city of
Abengourou. Since then, EPI was implemented across the entire country. In 1990, with
the support of partners, strategies such as social mobilization and advanced strategy were
implemented to improve routine immunization coverage the country. However, a survey
that was conducted in 1991 found that immunization coverage was still low. From 1991
until 1995, the National Institute of Public Hygiene was in charge of the EPI. Between
1994 and 1995, a change in the health system resulted in the creation of health districts,
and the EPI Executive Department, a new department charged with the implementation
of the EPI. In 2000, the EPI Executive Department became the EPI Management Head
Office. EPI Management Head Office works in close collaboration with the National
Institute of Public Hygiene for vaccines management, the Pharmacy of Public Health and
the Drug Head Office for vaccines and syringes supply and quality control, and the
Equipment Head Office for equipment maintenance. Immunization centers are located in
health facilities of the three level of the health care system. EPI in Côte d’Ivoire has
strengths such as the political will, a budget for vaccines and syringes supply, availability
of immunization services in all health districts, sufficient capacity of cold chain, and
diseases surveillance system. Despite these strengths, the EPI has weaknesses, such as
low performances of surveillance system, recurrent vaccines shortages, absence of cold
chain and vehicle renewal plan, insufficient supervision, and complex and slow process
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for accessing GAVI financial support (Direction de Coordination du Programme Elargi
de Vaccination, 2010).
Routine immunization schedule
At the beginning of the EPI in Côte d’Ivoire, the immunization schedule included
vaccines against six basic diseases which are tuberculosis, diphtheria, pertussis, tetanus,
poliomyelitis, and measles, as reported by Lim, Stein, Charrow, and Murray (2008). Over
the time, some diseases were targeted and other vaccines were added. In 2013, the routine
immunization schedules included 9 vaccines with 6 vaccines against the 6 basic diseases
and 3 against hepatitis B, Heamophilus influenza b infections, and yellow fever (WHO,
2014).
EPI immunization schedule takes into account WHO recommendations with 5 contacts
for children under 1 year of age (Table 1) and 5 contacts for women (Table 2). Children
and women are vaccinated free of charge in routine immunization centers.

Table 1. EPI routine immunization schedule for children under 1 year of age, Côte d’Ivoive
Age

Vaccine

At birth

BCG, OPV0

6 weeks

OPV1, DPT-HepB-Hib1

10 weeks

OPV2, DPT-HepB-Hib2

14 weeks

OPV3, DPT-HepB-Hib3

9 months

Measles, Yellow fever

Source: Plan d’introduction du vaccin contre le pneumocoque dans le PEV de routine en Côte
d’Ivoire
Pneumococcal vaccine introduction plan in EPI in Côte d’Ivoire
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Table 2. EPI tetanus toxoid routine immunization schedule for childbearing age
women, Côte d’Ivoive
Period
Vaccine
First contact

TT1

1 month after the first dose

TT2

1 month after the second dose

TT3

1 month after the third dose

TT4

1 year after the fourth dose

TT5

Source: EPI internet site (http://pev.site90.net/index.htm#)

Characteristics of vaccines of the EPI in Côte d’Ivoire
Vaccines that are included in EPI routine immunization schedule are monovalent (contain
only one antigen) including BCG, measles, and yellow fever vaccines, or polyvalent
(contain more than one antigen) such as diphtheria-tetanus-pertussis-hepatitis BHaemophilus influenza b, and polio vaccines. Both monovalent and polyvalent vaccines
require a temperature between 2°C and 8 °C. Vaccine are stable for 3 to 4 years from the
manufacturing date within this temperature range (WHO, 2011a).
BCG
Bacillus Calmette-Guérin or BCG is tuberculosis vaccine. It originates from
mycobacterium bovis. There are many strain of mycobacterium bovis but the most
broadly used in routine immunization program worldwide are “Danish 1331” strain,
“Tokyo 172” strain, and “Moscow” strain. BCG is administered through intradermal
route in the insertion region of the deltoid on the right arm. The dose used to vaccinate a
child is 0.05 ml. It is important to emphasize that HIV-positive children should not be
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vaccinated with BCG. Usually BCG injection resulted in a scar at the injection site about
three month later. The presence of the scar is an evidence for previous BCG vaccination.
Protection acquired after neonatal BCG vaccination can last 10 to 20 years or more. This
protection is useful in prevention of military tuberculosis and tuberculous meningitis
which are severe childhood disease. In addition, research showed that BCG provides also
protection against leprosy, Buruli ulcer, and glandular disease due to other environment
mycobacteria. BCG injection can be followed by adverse events. These events are mainly
an ulcer at the injection site, a local injection-site abscess, suppurating lymphadenitis or
local lymphadenopathy, osteitis or osteomyelitis, and dissemination of BCG (WHO,
2011b).
DTP-HepB-Hib
DPT-HepB-Hib or pentavalent consists of a combination of five vaccines and provides
protection against diphtheria, pertussis, tetanus, hepatitis B, and Haemophilus influenza
type b infections.
Diphtheria vaccine is made of diphtheria toxoid obtained by action of
formaldehyde on diphtheria toxin. This toxin is produced by a bacterium Corynebacterium diphtheriae. Diphtheria vaccine dosage unit is the limit of flocculation
(Lf). Each dose of children vaccines contain 7.5 to 25 Lf while adult and adolescents’
vaccines contain 2 to 3 Lf per dose. Adolescents and adults’ vaccine contain less unit
because they are more sensitive to local and systemic reactions associated with diphtheria
vaccine. It is said that 0.01 IU/mL of circulating diphtheria antitoxin provides immunity
against the disease. The duration of immunity after diphtheria vaccination varies between
early and more recent studies, and between countries. Studies conducted in US in the
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1960s found that 10% of children lost immunity 7 to 13 years after primary immunization
series whereas in the late 1980s research showed that 10% of children lost immunity after
one year, 67% after 3 to 13 years, and 83% after 14 to 23 years as reported by the WHO
(2009a). However, in Italy and United Kingdom, research found that, four to eight years
after the primary series of three doses, 96% to 100% of immunized children had
protective antibodies. These different findings may attributed to diverse immunization
schedules, different vaccines, or diverse level of exposure to Clostridium diphtheriae
natural consolidation of diphtheria immunity as reported by the WHO (2009a). Side
effects associated with diphtheria vaccine are erythema, and swelling at the injection-site,
and transient febrile (WHO, 2009a).
Tetanus vaccine is made of tetanus toxoid which is obtained by inactivation of
tetanus toxin by formaldehyde. Tetanus toxin is produced by Clostridium tetani which is
an anaerobic bacterium. Tetanus toxoid induces the production of tetanus antitoxins.
Antitoxins produced by mother by active immunization passes the fetus through the
placenta and prevent neonatal tetanus. The minimum antitoxin protective level is 0.01
IU/ml. The degree as well as the duration of protection increases with the number of
doses of vaccine received. One dose alone induces only little or no immunity. The second
doses produces a level of antitoxin greater than the minimum protective level of 0.01
IU/ml. The third dose induces a protection, which last at least five years. The fourth and
the fifth dose ensure immunity for at least 10 and 20 years, respectively. It is important to
underline that immunity decline over the time.

The most common adverse effects

associated with tetanus vaccine are local swelling and pain. In addition, malaise, fever,
and headache have been reported. Finally, brachial neuropathy (an estimated 0.5 to 1 case
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per 100 000 vaccine recipients) and anaphylactic reaction (four cases in about 2 million
doses administered) occur after tetanus vaccination (WHO, 2007a).
There are different types of pertussis or whooping cough vaccines – the wholecell pertussis vaccines (wP vaccines), and the acellular pertussis vaccines (aP vaccines).
These vaccines protect against effects of pertussis toxin produced by Bordetella pertussis,
which is the pathogenic agent of pertussis or whooping cough. Since the wP vaccines are
composed of killed whole bacteria, they induce a large immune response against many
antigens. Both aP and wP antigens are mainly associated with diphtheria and tetanus
toxoids to produce DTaP and DTwP vaccines. A combination with additional antigens
(hepatitis B antigen and haemophilus inflenzae type b polisaccharide) is possible by given
DTaP-HepB-Hib and DTwP-HepB-Hib vaccines. The degree of protection induced by
the pertussis vaccines increases with the number of doses received, and decrease over the
time. Research found that protection acquired by vaccination lasts 7 to 14 years. Pertussis
vaccines are associated with local reactions including warmth, tenderness, redness, and
swelling, and systemic reactions such as fever, fretfulness, vomiting, and anorexia.
Monovalent vaccines (vaccine containing one pertussis antigen) have less local sideeffects compare to combination vaccines. Overall, combination vaccines are safe,
efficacious, and are used in EPI routine immunization worldwide (WHO, 2010).
Hepatitis B vaccine is made of hepatitis B virus surface antigen (HBsAg). There
are two type of hepatitis B vaccine – plasma derived vaccine, and recombinant DNA
vaccine. Hepatitis B vaccine is administered by intramuscular route. The preferred
injection site is the anterolateral thigh for infants and children less than 2 years, and the
deltoid muscle for older children and adults.
11

Anti-HBs antibody level of more than 10 IU/L, measured 1 to 3 months after a complete
immunization schedule defines the seroprotection against hepatitis B virus infection.
Antibodies anti-HBs decrease quite rapidly after the primary immunization series and
more slowly afterward. Protection acquired by a complete immunization series can last
15 years after vaccination. HBsAg is combined with other antigens or toxoids to give
DTP-HepB-Hib. Hepatitis B vaccine can be administered simultaneously with other
vaccines such as BCG, DTP, polio, measles, and yellow fever vaccines. Hepatitis B
vaccine is not contraindicated during pregnancy or lactation but individuals with a history
of allergic reaction to the vaccine’s components are often advised not to receive the
vaccine. Adverse effects associated with hepatitis vaccine frequently include local pain,
myalgia and transient fever, and rarely severe anaphylactic reactions with an estimated
risk of 1.1 cases per million doses administered (WHO, 2011a).
Haemophilus influenzae type b (Hib) vaccine is made of purified Hib capsular
polysaccharide (PRP) linked (conjugated) to a protein carrier. PRP can be conjugated to
three type of protein carrier - tetanus toxoid, a mutated non-toxic diphtheria toxin, and a
Neisseria meningitides type b outer membrane protein complex. Hib vaccination induces
the production of antibodies anti-PRP. The level of anti-PRP determines the term of
protection. Hence, short-term and long-term protections are characterized by anti-PRP
concentration of 0.15 μg/ml and 1.0 μg/ml, respectively. Hib vaccine can be combined
with diphtheria-tetanus-pertussis (DTP) and hepatitis B (HepB) vaccines to give DTPHepB-Hib. Also, Hib vaccine can be administered at the same time with BCG, DTP,
measles, polio, HepB, yellow fever vaccines, and vitamin A supplementation. Hib
vaccine had a huge impact on the decrease of Hib infections in both developed and
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developing countries. For example, Hib disease has mostly disappeared in the United
States, Canada, Australia, New Zealand and Western Europe due to the introduction of
Hib vaccine into routine childhood immunization programs. In addition, in Malawi, the
introduction of Hib vaccine into the EPI decreased Hib disease by 87% in children under
2 years and by 88% in children under 5 years. Moreover, in the Gambia, the incidence of
Hib meningitis in infants decreased from 200 per 100 000 to 21 per 100 000 due to the
introduction of Hib vaccine into the EPI in 1997 as reported by the WHO (2007b).
Despite the efficacy of Hib vaccine, failure can occur in a vaccinated population due to
factors such as prematurity, immunoglobulin deficiency, malignancy, neutropenia, and
modification in Hib structure (WHO, 2007b).
OPV
There are two type of polio vaccine – live attenuated vaccine or oral polio vaccine (OPV)
and inactivated polio vaccine (IPV) or injectable vaccine. Both OPV and IPV are made of
polio virus. There are three types of polio virus - type 1, type 2, and type 3. The vaccine
can be monovalent (contains one type of polio virus), bivalent (contains 2 types of virus),
or trivalent (contains the three types of virus). Polio vaccine included in EPI vaccine is
trivalent IPV or OPV. IPV is mostly used in developing countries, whereas OPV is
utilized in developing countries. Polio vaccine induces the production of serum antibody
and secretory antibody. Individuals are protected against a specific type of poliovirus if
they produce a type-specific serum-neutralizing antibody, although serum neutralizing
antibody level needed for protection against clinical illness has not been determined.
Secretory immunoglobulin A (IgA) antibody provides a local barrier to poliovirus
infection. One to three weeks after administration, OPV induces the production of
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secretory IgA antibody (in the intestine and the nasopharynx), which inhibits wild virus
replication in the intestine. In addition, OPV multiplies in the intestine and disseminated
from vaccinated individuals to unimmunized persons who can consequently produce
secretory IgA antibody. Secretory IgA antibody is said to be useful in protecting people
and in decreasing the rate of transmission of wild poliovirus by immune individuals.
These secretory IgA can persist for 5 to 6 years. Trivalent OPV is recommended for EPI
in developing countries due to its low cost, superiority in bestowing intestinal immunity,
ease of administration, and the possibility to infect household and community contacts
secondarily. OPV can cause paralysis as an adverse effect. In the OPV series, the relative
frequency of paralysis associated with the initial dose is estimated to 1 case per 700 000
doses, and one case per 6.9 million ulterior doses. Usually, live vaccines are not
administered to immune-compromised individuals. However, in countries where HIV
infection is a problem, asymptomatic HIV positive persons are vaccinated in accordance
with EPI schedule. An alternative to OPV for vaccination in HIV positive children is
IPV. In 1988, the World Health Assembly decided the global eradication of
poliomyelitis. To achieve polio eradication, it is necessary to reach a high level of OPV
coverage. Supplementary immunization activities may be implemented in countries
where routine immunization may not be sufficient to stop wild polio virus transmission.
Additional doses of OPV should be administer to children under 1.5 years in routine
immunization in order to maintain immunity against the three type of polio virus in
countries where the circulation of wild poliovirus has been stopped or largely reduced
(WHO, 1993a).
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Measles vaccine
Measles vaccine is made of measles wild attenuated virus. Different wild-type strain such
as Edmonston, Schwartz, Moraten, Leningrad, and Shanghai are used to produce measles
vaccine. Attenuated measles virus can be associated with rubella and mumps antigens to
give measles-rubella vaccine (MR) or measles-rubella-mumps vaccine (MMR). The usual
route of injection of measles vaccine is the subcutaneous route; however, it can be
administer intramuscularly. As the natural measles virus infection, measles vaccine
induces cellular and humoral response but these responses are lower in terms of
magnitude and duration compared to those generated by natural infection. The immunity
conferred by measles vaccination last for decades, and the level of neutralizing antibodies
needed to insure a clinical protection against the disease is ≥ 120 mIU/mL.
Many factors (age, sex, passively-acquired maternal IgG antibodies, HIV infection and
other immunosuppressive conditions, concurrent acute infections, nutrition status, host
genetics) influence immune response to vaccination. For example, older infants produce
better responses compare to younger infants; girls produce higher antibodies than boys;
passively-acquired maternal IgG antibodies, HIV infection, concurrent acute infections,
and malnutrition reduce immune responses; genetic differences can lead to difference
level of immune response after vaccination. Adverse event are associated with measles
vaccine. The frequent adverse effects are fever, and injection-site pain and tenderness.
Rarely, thrombocytopenia and Anaphylactic reactions can occur (WHO, 2009b).
Yellow fever vaccine
Yellow fever (17 D vaccine) is made of live attenuated human yellow fever virus.
Different strains are used to produce yellow fever vaccine; however, these strains came
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from the same primary strain. The vaccine is administered through subcutaneous route to
a dose of 0.5 ml from 6 months of age because cases of encephalitis were reported in
children of 4 months and younger. Yellow fever vaccine induce the production of
antibodies (neutralizing, hemagglutination inhibition, and complement fixation
antibodies) which protect immunized individuals against the disease. The protection
conferred by vaccination last many decades. In many countries’ EPI routine
immunization programs, yellow fever vaccine is administer simultaneously with measles
vaccine at 9 months of age. Yellow fever vaccine is a lyophilized vaccine which loses all
its potency within one hour when it is reconstituted with diluent at 37°C. Therefore, it
must be reconstituted with refrigerator-temperature diluent and kept in an ice-bath in
order to maintain its potency for up to 3 hours. Yellow fever vaccine is well tolerated.
Therefore, adverse events association with the vaccine are mild and limited to low grade
fever and headache (WHO, 1993b).
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CHAPTER III
METHODS AND PROCEDURES
Data source and sample size


Data Source

The 1998-1999 and 2011-2012 Côte d’Ivoire Demography and Health Surveys (DHS)
data were used for this study. These data were obtained from DHS data at
http://www.dhsprogram.com/data/dataset_admin/download-datasets.cfm, after a written
request explaining the purpose of the study. This request was followed by a written
agreement, from the Demographic and Health Survey Program and ICF International,
which authorized the data use.
Côte d’Ivoire DHS was based on a random sampling with two stratification levels and
two-stage cluster sampling survey. The first level of stratification was regions
stratification. The second level was the stratification of rural and urban areas within each
region. This stratification resulted in a list of all rural and urban strata of the country.
From this list, strata were selected by random sampling. Subsequently, household to be
surveyed were randomly selected from the selected strata. The number of households
included in the survey was proportional to the stratum size and the number of strata
selected was proportional to the region size (Republique de Côte d’Ivoire, 2001;
Republique de Côte d’Ivoire, 2013).
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Study sample

The study sample was based on children data set from 1998-1999 DHS which contained
1992 cases, and children data set from 2011-2012 DHS which contained 7776 cases.
Only children aged 12 to 59 months were eligible for the study. In addition, cases with
missing data were excluded from the data sets. The sample was 3878 children
representing 1326 children from 1998-1999, and 2552 children from the 2011-2012 DHS.

Definition of the variables


Dependent variable

The outcome variable was vaccination defined as “not fully unimmunized”. A child
defined as not fully unimmunized if he/she did not received at least one of the following
vaccines: BCG, the third dose of pentavalent (DTP-HepB-Hib 3), the third dose of polio
(polio 3), and measles vaccine.


Independent variables

Independent variables in the study included child’s sex, age, birth place, birth order,
number of under-five children in the household, mother’s age, mother’s highest
education, mother’s access to media (radio, television, and/or newspaper), mother’s
literacy, head of the household, type of place of residence, and religion.

Statistical analysis
Descriptive analysis was performed to examine the rate of non-immunization by year.
The Chi-square test was computed to compare differences among variables subgroups
across years. Differences in rates of BCG, DPT3, polio3, and measles vaccinations were
18

computed to determine the trend of children who remains unimmunized for these
vaccines. Spearman correlation analysis was performed to examine the relation between
studied variables. Univariate logistic regression analysis was performed to examine the
association between the dependent variable and each independent variable. The measure
of association was the odds ratio (OR) from the logistic regression analyses with the 95%
confidence interval (CI) used to determine statistical significance. Variables with a pvalue less than .05 in the univariate analysis were included in the multivariate logistic
regression analysis. Multivariate analysis was performed to determine predictors of
immunization status using stepwise method logistic regression analysis.
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CHAPTER IV
RESULTS
A. Descriptive
Table 3. Proportional distribution of selected variables, Côte d’Ivoire, 1998-1999 and 2011-2012
Variables
Total
1998-1999
2011-2012
N (%)
N (%)
P*
Number of children aged 12-59
months
3878
1326 (100)
2552 (100)
Not fully immunized children

1805

556 (41.9)

1249 (48.9)

.0001

Child sex
male
female

652 (49.2)
674 (50.8)

1264 (49.5)
1288 (50.5)

.832

3878

351 (26.5)
371 (28.0)
306 (23.0)
298 (22.5)

718 (28.1)
693 (27.2)
612 (24.0)
529 (20.7)

542 (40.9)
784 (59.1)

1149 (45.4)
1380 (54.6)

324 (24.4)
247 (18.6)
195 (14.7)
145 (11.0)
415 (31.3)

518 (20.3)
498 (19.5)
405 (15.9)
333 (13.0)
798 (31.3)

Mean (SD)
2.30 (1.69)

Mean (SD)
2.37 (1.44)

Child age (months)
12-23
24-35
36-47
48-59
Child birth place
Home
Health facility
Child birth order
1rst
2nd
3rd
4th
≥5th

3878

3855

3878

Number of under-five children
in the household

*P value is from the Chi-square test comparing 1998-1999 to 2011-2012 data
*t value is from the independent samples t test
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.451

.007

.025

.20

Distribution of selected variables for year 1998-1999 and year 2011-2012 are presented
in Table 6. As shown, distribution of selected variables varied across years.

Table 4. Proportional distribution of selected variables, Côte d’Ivoire, 1998-1999 and 2011-2012
(continue)
1998-1999
2011-2012
Variables
Total
N (%)
N (%)
P
Mothers’ age (years)
15-24
392 (29.5)
690 (27.0)
25-34
636 (48.0)
1253 (49.1)
35-44
3878
268 (20.2)
543 (21.3)
.381
45-49
30 (2.3)
66 (2.6)
Mothers’ education
No education
Primary
Secondary and higher

3878

786 (59.3)
371 (28.0)
169 (12.7)

1751 (68.6)
587 (23.0)
214 (8.4)

.0001

Mothers’ literacy
Can read
Cannot read

3877

467 (35.2)
858 (64.8)

556 (21.8)
1996 (78.2)

.0001

Head of the household
Man
Woman

3878

1146 (86.4)
180 (13.6)

2181 (85.5)
371 (14.5)

.415

Media access
No
Yes

3878

426 (32.1)
900 (67.9)

1008 (39.5)
1544 (60.5)

.0001

Place of residence
Urban
Rural

3878

777(58.6)
549 (41.4)

849 (33.3)
1703 (66.7)

.0001

Religion
Catholic
Protestant
Muslim
Traditional, no religion

3878

284 (21.4)
184(13.9)
584 (44.0)
274 (20.7)

412 (16.1)
527 (20.7)
1170 (45.8)
443 (17.4)
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.0001

There were statistically significant difference between subjects’ maternal education,
maternal literacy, media access, place of residence, and religion in 1998-1999 and year
2011-2012 (p < .001). As shown, proportion of eligible subjects’ mothers representing no
education, living in urban setting, and of Catholic religion were greater in 1998-1999.
Fewer subjects had access to media in 2011-2012 compared to 1998-1999.

Table 5. Proportional distribution of not immunized children per vaccine, Côte d’Ivoire,
1998-1999 and 2011-2012
1998-1999
2011-2012
*Absolute
difference
Vaccine
P
Sample
Not
Sample
Not
size
immunized
size
immunized
N (%)
N (%)
BCG

1326

194 (14.6)

2552

461 (18.1)

.007

3.5

DPT 3

1326

432 (32.6)

2552

893 (35.0)

.133

2.4

Polio 3

1326

458 (34.5)

2552

743 (29.1)

.001

-5.4

Measles

1326

314 (23.7)

2552

783 (30.7)

.0001

7.0

*Absolut difference is the difference of not fully immunized percentage between 2011-2012 and
1998-1999

Table 5 provides distribution of subjects who were not immunized in Cote d’Ivoire, in
1998-1999 and 2011-2012. As shown, the rate of non-immunization for BCG, measles
were higher in 2011-2012 compared to 1998-1999 (p < .001). The rate of nonimmunization for polio 3 was higher in 1998-1999 than 2011-2012 with rates of 34% and
29.1% respectively. However, there was no difference in the rate of non-immunization
for DPT 3 for the study period (p = .133).
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Table 6. Spearman’s correlation coefficient for selected variables, Côte d’Ivoire, 1998-1999 and 2011-2012
Year 2011-2012
Not fully
vaccinated

Child's
age in
months

Birth
order
number

Place of
delivery

Sex of
child

Type of
place of
residenc
e

Age 5year
groups

Access
to
media

Highest
educatio
nal level

Literacy

Religion

Sex of
household
head

.023

Number
of
children
5 and
under
.142**

Not fully vaccinated

1

.007

-.200**

.010

.157**

-.038*

-.158**

-.150**

.181**

.151**

-.068**

Child's age in months

-.009

1

.017

.054**

-.036

.006

.006

.148**

.004

-.017

.018

-.001

-.011

Birth order number

.100**

.027

1

.116**

-.139**

-.017

.135**

.698**

-.098**

-.207**

.158**

.045*

-.088**

.036

.010

.159**

1

-.138**

.012

.181**

-.017

-.085**

-.102**

.128**

.113**

-.069**

Year

Number of children 5
and under
Place of delivery

-.326**

.015

-.115**

-.104**

1

-.032

-.344**

-.034

.258**

.238**

-.218**

-.092**

.055**

1998-

Sex of child

.001

.049

-.027

-.008

-.008

1

.031

-.013

-.024

-.009

.009

-.002

-.021

1999

Type of place of
residence
Age 5-year groups

.251**

.005

.087**

.176**

-.481**

.009

1

.021

-.332**

-.215**

.252**

.080**

-.072**

.050

.130**

.708**

.084**

-.027

.017

.021

1

-.048*

-.108**

.059**

-.013

-.050*

Access to media

-.247**

-.055*

-.175**

-.047

.269**

-.024

-.294**

-.178**

1

.316**

-.308**

-.183**

.058**

Highest educational
level
Literacy

-.212**

-.006

-.225**

-.133**

.285**

-.041

-.215**

-.137**

.369**

1

-.776**

-.261**

.129**

.230**

.002

.218**

.131**

-.273**

.051

.220**

.136**

-.356**

-.863**

1

.242**

-.130**

Religion

.186**

.010

.081**

.149**

-.221**

.055*

.145**

.014

-.146**

-.292**

.303**

1

-.132**

Sex of household head

.011

-.022

-.069*

-.078**

.020

.033

-.043

.020

.060*

.038

-.072**

-.087**

1

Variable

**. Correlation is significant at the 0.01 level (2-tailed)
*. Correlation is significant at the 0.05 level (2-tailed)
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Table 6 provides Spearman’s correlation coefficient for 1998-1999 and 2011-2012
variables. As shown, there was a significant positive relationship between incomplete
immunization and children birth order, place of residence, maternal literacy, and religion
in 1998-1999. There was a significant negative relationship between incomplete
immunization and child birth place, access to media, and maternal education in 19981999. In 2011-2012, there was a significant positive relationship between incomplete
immunization and number of children in the household, place of residence, maternal
literacy, and religion. However, there was a significant negative relationship between
incomplete immunization and child birth place, maternal age group, access to media,
education, and sex of household head.
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B. Univariate analysis
Table 7. Univariate analysis of selected variables and Odds of not being fully
immunized, Côte d’Ivoire, 1998-1999 and 2011-2012
Not fully immunized
1998-1999
2011-2012
Variables
OR (95% CI)
P-value
OR (95% CI)
P-value
Child sex
male
1 (Reference)
1 (Reference)
female
1.00 (.80, 1.25) .966
1.04 (.89, 1.21)
.600
Child age
(months)
12-23
24-35
36-47
48-59

1.05 (.77, 1.44)
.93 (.68, 1.27)
.95 (.69, 1.32)
1 (Reference)

.737
.680
.783

1.02 (.81, 1.28)
.79 (.63, 1.00)
1.03 (.82, 1.30)
1 (Reference)

.83
.05
.76

.0001

Child birth place
Home
Health facility

3.95 (3.13, 4.98) .0001
1 (Reference)

2.26 (1.92, 2.65)
1 (Reference)

Child birth order
1rst
2nd
3rd
4th
≥5th

1 (Reference)
.93 (.66, 1.32)
1.04 (.725, 1.50)
1.15 (.77, 1.72)
1.62 (1.21, 2.18)

1 (Reference)
1.02 (.80, 1.31)
.98 (.75, 1.27)
.98 (.74, 1.29)
1.14 (.91, 1.42)

.819
.887
.903
.231

1.21 (1.14, 1.28)

.0001

Number of underfive children in
the household

.709
.818
.483
.001

1.10 (1.02, 1.16) .006

The result of the univariate analysis of the association between selected child variables
and Odds of not being fully immunized in 1998-1999, and 2011-2012 is presented in
Table 7. As shown, and with the exception of child birth place and number of children
under 5 per household, child sex, and age were found not to be significantly associated
with child immunization.
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In 1998-1999, and 2011-2012 child birth place and increased number of children less
than 5 years per household were associated with increased Odds of not fully vaccinated.
In 1998-1999, and 2011-2012, birth at home, was associated with increased Odds of not
being fully immunized, with Odds ratio of 3.95 (95% CI=3.13-4.98) and 2.26 (95%
CI=1.92-2.65), respectively. Increased number of children per household was associated
with increased Odds of not being fully immunized, with Odds ratio of 1.10 (95%
CI=1.02-1.16) and 1.21(95% CI=1.14-1.28) in 1998-1999, and 2011-2012 respectively.
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Table 8. Univariate analysis of selected variables and Odds of not being fully
immunized, Côte d’Ivoire, 1998-1999, and 2011-2012 (continue)
Not fully immunized
1998-1999
OR (95% CI)
P-value

2011-2012
OR (95% CI)
P-value

.52 (.24, 1.11)
.50 (.24, 1.05)
.68 (.32, 1.47)
1 (Reference)

.094
.076
.337

1.72 (1.03, 2.89)
1.37 (.82, 2.27)
1.48 (.88, 2.50)
1 (Reference)

.038
.219
.135

5.38 (3.46, 8.37)
3.37 (2.11, 5.38)
1 (Reference)

.0001
.0001

2.45 (1.81, 3.31)
1.42 (1.02, 1.98)
1 (Reference)

.0001
.037

Media access
No
Yes

2.92 (2.30, 3.71)
1 (Reference)

.0001

1.92 (1.63, 2.25)
1 (Reference)

.0001

Literacy
Can read
Cannot read

1 (Reference)
2.80 (2.19, 3.58)

Head of the
household
Man
Woman
Place of residence
Urban
Rural

Variables
Mother’s age
(years)
15-24
25-34
35-44
45-49
Mother’s education
No education
Primary
Secondary and
Higher

Religion
Catholic
Protestant
Muslim
Traditional/no
religion

.0001

1 (Reference)
2.48 (2.03, 3.03)

.0001

1 (Reference)
1.06 (.77, 1.46)

.682

1 (Reference)
.67 (.54, .84)

.001

1 (Reference)
2.83 (2.26, 3.55)

.0001

1 (Reference)
1.97 (1.66, 2.33)

.0001

1 (Reference)
1.63 (1.09, 2.41)
1.97 (1.44, 2.67)
3.33 (2.34, 4.73)

.015
.0001
.0001

1 (Reference)
1.48 (1.14, 1.93)
2.01 (1.59, 2.54)
2.71 (2.06, 3.58)

.003
.0001
.0001

In 1998-1999 as well as in 2011-2012, the number of children not fully immunized was
associated with mother’s education, media access, literacy, place of residence, and
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religion. The dependent variable was associated with the variable “Head of the
household” in 2011-2012 only. However, the number of children not fully immunized
was not associated with mother’s age in 1998-1999 and in 2011-2012 also.

C. Multivariate analysis

Table 9. Multivariate analysis of selected variables and Odds of not being fully
immunized, Côte d’Ivoire, 1998-1999, and 2011-2012
Not fully immunized
1998-1999
2011-2012
Variables
Adj. OR(95% CI) P-value Adj. OR(95% CI) P-value
Child birth place
Home
2.57 (1.96, 3.37)
.0001
1.72 (1.44, 2.05)
.0001
Health facility
1 (Reference)
1 (Reference)
Media access
No
Yes

1.82 (1.38, 2.38)
1 (Reference)

Literacy
Can read
Cannot read

1 (Reference)
1.95 (1.19, 3.20)

Place of residence
Urban
Rural
Religion
Catholic
Protestant
Muslim
Traditional and no
religion

1.27 (1.06, 1.53)
1 (Reference)

.009

1 (Reference)
1.59 (1.27, 1.99)

.0001

.008

1 (Reference)
1.38 (1.04, 1.83)

.023

1 (Reference)
1.29 (1.06, 1.58)

.002

1 (Reference)
1.72 (1.12, 2.64)
1.71 (1.21, 2.43)
1.89 (1.28, 2.79)

.013
.002
.001

1 (Reference)
1.32 (1.00, 1.74)
1.74 (1.36, 2.23)
1.82 (1.36, 2.44)

.049
.0001
.0001

1.13 (1.06, 1.20)

.0001

Number of under-five
children in the household

NA

Mother’s education
No education
Primary
Secondary and higher

1.17 (.59, 2.30)
1.85 (1.12, 3.07)
1 (Reference)

NA = Not applicable
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.0001

.650
.016

NA

The result of the multivariate logistic regression analyses of the association between
selected variables and odds of not being fully immunized in 1998-1999, and 2011-2012
are presented in Table 9. Child birth place, media access, literacy, place of residence, and
religion were associated with odds of not being fully immunized in 1998-1999 as well as
in 2011-2012. Increased number of children less than five years in the household was
associated with increased odds of not being fully immunized only in 2011-2012.
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CHAPTER V
DISCUSSION AND CONCLUSION


Possible reasons for the increase of not fully unimmunized children

In this study we examined the trend of socio-demographic factors that are associated with
immunization status among children aged 12 to 59 months using DHS data from 19981999 and 2011-2012. The number of not fully unimmunized children in 2011-2012
sample (1249, 48.9%) compared to those of 1998-1999 (556, 41.9%) was statistically
significant (P = .0001). This difference could be explained by many reasons.
The first reason may be due to the insufficiency of supply of immunization
service. The strategy Reach Each District has been implemented in all the health districts
through the country using first contact health facilities which offer immunization
services. A study conducted in 2010, in order to write the External Review of Expanded
Program on Immunization, found that the strategy Reach Each District was insufficiently
implemented in some health districts. Immunization supply service was insufficient for
all types of immunization strategy: fixe, advanced, and out of reach strategy. Some
vaccines were not administered during immunization session mainly because health
personnel wanted to reduce vaccine wastage, and because of vaccines shortage (Direction
de Coordination du Programme Elargi de Vaccination, 2010).
The second reason may be attributed to insufficiency in immunization service use.
The study conducted in 2010, mentioned above, found that the access to immunization
program which is assessed by DPT1 and TT1 coverage was high (more than 90% for
each of them). However, continuity of immunization service which is assessed by
dropout rates of DPT1-DTC3, DPT1-MCV, TT1-TT2, and TT1-TT3 was low (dropout
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rates was far beyond the threshold of 10%). For example, in 2011, only 33 (21%) health
districts out of 82 had a dropout rate less than 10% (Direction de Coordination du
Programme Elargi de vaccination, 2011b; Direction de Coordination du Programme
Elargi de vaccination, 2013), and the dropout rate at of DPT1-MCV was 26% at national
level (WHO, and UNICEF, 2011).
The third reason may be due to vaccines shortage. The country experienced
vaccines shortages for months and in different years. For instance, in 2010, BCG, TT,
yellow fever, and measles vaccine were out of stock for 2, 2, 5, and 1 months
respectively. The following year, 2011, pentavalent vaccine (DPT-HepB-Hib) was out of
stack for 3 months, and auto-disable syringes were out of stock for 5 months (Direction
de Coordination du Programme Elargi de vaccination, 2011a).
The fourth reason may be due to financial problems. Almost all financial
institutions and private companies had to close for security reasons, and for the cessation
of financial operations of the Central Bank of West African Countries with Côte d’Ivoire
during the post-electoral period. This situation severely affected the economy of the
country. Consequently, vaccines suppliers did not get paid. Therefore, vaccines supply
was suspended. This suspension led to vaccines shortage over the time (Direction de
Coordination du Programme Elargi de vaccination, 2011a).
The fifth reason may be due to the social and military crisis. The Côte d’Ivoire
experienced a sociopolitical crisis since 2002. This crisis worsened after the presidential
election, in November 2010, which led to a war between March 2011 and Mai 2011. The
crisis had a negative impact on heath system in general, and especially on immunization
system. For example, the government decreased his contribution on health expenses. In
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addition, losses of cold chain equipment, vehicles, and motorbikes were reported in the
vast majority of health districts. Moreover, vaccines and syringes shortage was reported
(Direction de Coordination du Programme Elargi de vaccination, 2011a).



Factors associated with immunization status

Birth place
Birth place was associated with immunization status in 1998-1999 as well as in
2011-2012. In 1998-1999, children born at home were 2.5 times more likely not to be
fully immunized compared to those born at health facilities (95%CI = 1.91, 3.28). In
2011-2012, although the odd of not being fully immunized when born at home decreased
compared to 1998-1999, children born at home were 1.72 more likely to be not fully
immunized compared to those born at health facilities (95%CI = 1.44, 2.05). Our findings
are similar to those of previous studies (Nankabirwa, Tylleskär, Tumwine, Sommerfelt,
and Promise-ebf Study Group, 2010; Nath et al., 2007; Maina, et al., 2013, Komlan et al.,
2005). In Sub-Saharan African region, many women often give birth at home for reasons
such as lack of transport and/or funds, long distance to reach health facilities, and lack of
motivation (not necessary to deliver in a health facility) (Montagu, Yamey, Visconti,
Harding, and Yoong, 2011; Kitui J., Lewis S., and Davey G., 2013; Partnership for
maternal, newborn and child health, n.d.). The lack of motivation to deliver in a health
facility could be explained by social and cultural beliefs as reported by Montagu et al.
(2011).
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Place of residence
Place of residence was associated with immunization status in 1998-1999 and in
2011-2012 also. Children living in rural area were 1.38 more likely not to be fully
immunized compared to those of urban area in 1998-1999. In 2011-2012, children of
rural area were 1.29 more likely to have incomplete immunization than their urban
counterparts. Our findings confirmed those of previous studies conducted in Malawi
(Munthali, 2007), Benin (Komlan et al., 2005), and Ethiopia (Roy, 2010). However, other
studies conducted in Gambia (Payne et al., 2013), Malawi (Donsa, 2013), and in other
Sub-Saharan African countries (Wiysonge et al., 2012) found that children living in rural
areas were more likely to be not fully immunized compared to those of urban areas. In
rural areas, children incomplete immunization status could be explained by the long
distance between the place of residence and health facilities (Munthali, 2007) which
poses a problem of transport and cost of transport (Rainey et al., 2011). In urban areas,
mothers’ concern about being absent from work (Payne et al., 2013; Rainey et al., 2011),
and parents’ concern about vaccine adverse effects could explained children incomplete
immunization status.

Media access
Access to media was associated to the immunization status in 1988-1999 as well
as in 2011-2012. In 1998-1999, children of women who had no access to media were
1.82 times more likely to be incompletely immunized compared to those whose mothers
had access to media. In 2011-2012, the odd of being not fully vaccinated decreased
slightly. Children of women who had no access to media were 1.06 times more likely to
have incomplete immunization than their counterparts whose mothers had access to radio,
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television, and/or newspaper. Our findings confirmed those of previous studies which
reported that lack of mothers’ access to media increased the likelihood of their children to
be incompletely vaccinated (Bugvi et al. 2014; Donsa, 2013; Bosch-Capblanch et al.
2012, Wiysonge et al., 2012). Media played an important role in health in general, and
especially in children immunization. In Philippines, a communication campaign for
Expended Program on Immunization focused on measles, in Metro Manila region,
increased not only measles coverage (from 21 to 45 percent) but also all other vaccines
coverage (from 20 to 24 percent) within five months (Rasmuson M., 1990). Access to
media influenced immunization completion through behavior change (Noar, 2006;
Waisbord, and Larson, 2005). Information sprayed through media increases parents
awareness about immunization. Therefore, parents care-seeking behavior change;
eventually, they get their children vaccinated.

Literacy
Literacy was associated with immunization status in 1998-1999 and in 2011-2012
as well. In 1998-1999, children of women who could not read were 1.95 times more
likely to be incompletely immunized compared to those of women who could read. In
2011-2012, children of women who could not read were 1.59 times more likely to have
incomplete immunization compared to those of women who could read. Like our study,
previous research found that women literacy was associated with a higher likelihood of
having a child vaccinated (Edwards, 2010; Maina, et al., 2013). Literacy can be seen as a
proxy indicator for education level and consequently carry the identical profit of
education in the mother (Edwards, 2010). Education increases women’s understanding of
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health and consequently augment their use of maternal and children health services
(Greenaway, Leon, and Baker, 2012).

Implications/recommendations
Our study showed that birth place, place of residence, access to media, and
literacy are the strongest predictors of immunization status in Côte d’Ivoire. Therefore, to
address the issue of children incomplete immunization, health officials and particularly
the coordinator director of the Expended Program on Immunization, and health districts
directors should promote delivery at health facilities, access to media, literacy through
education, and focus immunization effort in rural area. To reach these objectives, health
minister should work in cooperation with education minister, and communication
minister. Moreover, future studies are needed to reexamine immunization predictors in
order to redirect efforts to get children vaccinated.

Limitations
The findings of our study should be interpreted in the light of some limitations.
First, recall bias cannot be ruled out as possible explanation for the findings of this study.
During data collection in this study, mothers provided account about the immunization
status of their children when the health card of the child was not available. Thus, we
cannot vouch for the rightness of what they say. In addition, wealth index of household
was not included the analysis because 1998-1999 data set did not contain this
information. The exclusion of wealth index, which has been found associated with
immunization status in other studies, could have an impact on immunization predictors
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found in our study. In this study, we did not use weighting scheme to correct for the
complex sampling methods that were used in DHS.

Conclusion
This study which examined the trend of socio-demographic factors associated
with children aged 12 to 59 months using 1998-1999 and 2011-2012 DHS data of Côte
d’Ivoire found that incompletely immunized children increased over the time. Looking at
the factors associated with immunization status, birth place, place of residence, access to
media, and literacy were the strongest predictors of immunization status. Health minister
and other health officials should take into account these immunization status predictors,
and work in cooperation with education minister, and communication minister in order to
address the issue of children incomplete immunization in Côte d’Ivoire. Finally, future
studies are needed to reexamine the trend of socio-demographic factors associated with
children immunization status in order to redirect efforts to get children vaccinated.
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